Gregory Zante

Gregory Zante

Finanzdirektor/CFO bei VIKING THERAPEUTICS, INC.

Vermögen: 12 Mio $ am 30.04.2024

53 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Gregory Zante

EinheitArt der EinheitIndustrie
150
Subsidiary Miscellaneous Commercial Services 150
Public Company Biotechnology 22
Public Company Pharmaceuticals: Major 12
9
Extinct Medical Specialties 9
7
Subsidiary Pharmaceuticals: Major 7
Calyx Therapeutics, Inc.
2
Private Company 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Gregory Zante

UnternehmenSektorVerknüpfte PersonenHauptposition
The Pennsylvania State University College/University

Vincent Sadusky

Jay Skyler

Donald Huffman

John Price

Edward A. Imbrogno

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Ray J. Groves

Brian S. Block

Vincent J. Love

Edward A. Imbrogno

Michele Anthony

Chairman

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Brian S. Block

J. Singleton

Michael Jackson

Craig Slutzkin

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Berkeley College/University

Henry Ward Wolff

Scott J. Matson

David A. Wilson

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

ELI LILLY AND COMPANY Pharmaceuticals: Major

William Ringo

Thomas Wiggans

Michael Morneau

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Santa Clara University College/University

Matthew Foehr

Dana Stalder

Tonya Chin

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Texas A&M University College/University

Jonathan Albert Graf

Michael Pearl

Undergraduate Degree

Graduate Degree

Miscellaneous Commercial Services

Thomas Wiggans

Steven Mento

Director/Board Member

Director/Board Member

Rutgers State University of New Jersey College/University

Steven Mento

Charles Rowland

Doctorate Degree

Masters Business Admin

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Henry Ward Wolff

William Ringo

Director/Board Member

Director/Board Member

Stanford University College/University

John Gloekler

Sona Saira Ramasastry

Graduate Degree

Graduate Degree

Pharmaceuticals: Major

Matthew Foehr

S. Rouan

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Matthew Foehr

S. Rouan

Corporate Officer/Principal

Corporate Officer/Principal

McGill University College/University

Dejan Ristic

Marianne Mancini

Undergraduate Degree

Undergraduate Degree

Albright College College/University

Brian S. Block

Anthony W. Gennaro

Undergraduate Degree

Undergraduate Degree

University of Wisconsin College/University

Blake E. Devitt

G. Steven Burrill

Masters Business Admin

Undergraduate Degree

COHU, INC. Semiconductors

John H. Allen

Harry L. Casari

Chief Administrative Officer

Director/Board Member

Miscellaneous Commercial Services

Brian S. Block

Michele Anthony

Corporate Officer/Principal

Corporate Officer/Principal

University of New Hampshire College/University

Diane M. McClintock

Michael Morneau

Undergraduate Degree

Undergraduate Degree

DERMIRA, INC. Pharmaceuticals: Major

William Ringo

Thomas Wiggans

Director/Board Member

Chief Executive Officer

College/University

Jay Skyler

Lisa M. Ondrula

Corporate Officer/Principal

Undergraduate Degree

Pharmaceuticals: Major

William Ringo

Thomas Wiggans

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Andrew Cox

Marc Smernoff

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Donald Huffman

Adam Stern

Director/Board Member

Director/Board Member

NABRIVA THERAPEUTICS PLC Pharmaceuticals: Major

Stephen Webster

Charles Rowland

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Stephen Webster

Charles Rowland

Director/Board Member

Director/Board Member

University of Georgia College/University

J. Paul Whitehead

David Lowrance

Undergraduate Degree

Undergraduate Degree

University of London College/University

Stephen Dilly

S. Rouan

Doctorate Degree

Graduate Degree

New York University College/University

J. Singleton

Dennis Brown

Masters Business Admin

Undergraduate Degree

Biotechnology

Stephen Dilly

Marianne Mancini

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

University of Illinois College/University

Harold Perry

David A. Wilson

Undergraduate Degree

Doctorate Degree

San Diego State University College/University

James S. Miele

Jill Marie Church

Undergraduate Degree

Undergraduate Degree

Indiana University College/University

Anthony W. Gennaro

Brian Lian

Masters Business Admin

Masters Business Admin

University of Tennessee College/University

William Rhodes

Mark Mosteller

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Michael D. Casey

William Ringo

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Diane M. McClintock

Corporate Officer/Principal

INTUIT INC. Packaged Software

Dana Stalder

Corporate Officer/Principal

WATTS WATER TECHNOLOGIES, INC. Industrial Machinery

Diane M. McClintock

Investor Relations Contact

QUANTUM CORPORATION Computer Peripherals

Dana Stalder

Corporate Officer/Principal

Dartmouth College College/University

Stephen Webster

Undergraduate Degree

Biotechnology

Stephen Webster

Director of Finance/CFO

Statistik

International

Vereinigte Staaten 44
Kanada 3
Frankreich 2
Irland 2
Österreich 2

Sektoral

Consumer Services 20
Health Technology 18
Commercial Services 9
Electronic Technology 4
Technology Services 2

Operativ

Director/Board Member 443
Director of Finance/CFO 193
Corporate Officer/Principal 193
Independent Dir/Board Member 126
Undergraduate Degree 82
  1. Börse
  2. Insiders
  3. Gregory Zante
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT